Skip to content

Clinical trials

Atherosclerosis trials in Mexico

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Atherosclerosis Country / region: Mexico Clear all

20 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20081
20111
20121
20141
20171
20182
20212
20223
20243
20253
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Recruiting5
Active, not recruiting4
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Amgen3
Eli Lilly and Company3
CSL Behring2
GlaxoSmithKline2
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran2
Novartis Pharmaceuticals2
AstraZeneca1
Bayer1
David Sanchez Garcia1
Hilda Elizabeth Macías Cervantes1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Atherosclerosis20
Cardiovascular Diseases5
Coronary Artery Disease5
Peripheral Arterial Disease4
Heart Diseases3
Myocardial Infarction3
Diabetes Mellitus, Type 22
Kidney Failure, Chronic2
Stroke2
Acquired Immunodeficiency Syndrome1

Trials

Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.